We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+11.1%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
AUM
$1.88B
AUM Growth
-$1.56B
Cap. Flow
-$1.8B
Cap. Flow %
-95.56%
Top 10 Hldgs %
34.13%
Holding
1,673
New
146
Increased
88
Reduced
1,274
Closed
154

Sector Composition

Rank Sector Weight
1 Technology 13.28%
2 Financials 8.7%
3 Healthcare 5.71%
4 Industrials 5%
5 Consumer Discretionary 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HY icon
701
Hyster-Yale Materials Handling
HY
$593M
$57.3K ﹤0.01%
922
-922
-50% -$43.9K
KHC icon
702
Kraft Heinz
KHC
$30.4B
$57.2K ﹤0.01%
1,546
-798
-34% -$27.1K
NICE icon
703
Nice
NICE
$5.29B
$56.9K ﹤0.01%
285
-201
-41% -$36.2K
GNRC icon
704
Generac Holdings
GNRC
$11.9B
$56.7K ﹤0.01%
438
-438
-50% -$48.1K
LEA icon
705
Lear
LEA
$7.19B
$56.5K ﹤0.01%
400
-400
-50% -$53.6K
FMC icon
706
FMC
FMC
$1.42B
$56.5K ﹤0.01%
895
-1,829
-67% -$106K
DT icon
707
Dynatrace
DT
$12.1B
$56.1K ﹤0.01%
1,026
-854
-45% -$43.2K
VIOO icon
708
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.13B
$56K ﹤0.01%
565
-565
-50% -$50.4K
ONC
709
BeOne Medicines Ltd
ONC
$33.8B
$55.9K ﹤0.01%
310
-302
-49% -$54.6K
NTAP icon
710
NetApp
NTAP
$32.9B
$55.3K ﹤0.01%
628
-628
-50% -$50.6K
RCKT icon
711
Rocket Pharmaceuticals
RCKT
$348M
$55.1K ﹤0.01%
1,840
-2,350
-56% -$51.9K
BND icon
712
Vanguard Total Bond Market
BND
$157B
$54.2K ﹤0.01%
737
+515
+232% +$36.4K
FLR icon
713
Fluor
FLR
$7.29B
$54.1K ﹤0.01%
1,382
-1,382
-50% -$51.1K
BEPC icon
714
Brookfield Renewable
BEPC
$6.12B
$54K ﹤0.01%
1,875
-1,875
-50% -$47.8K
PR
715
Permian Resources
PR
$17.9B
$53.9K ﹤0.01%
3,960
-2,530
-39% -$34.6K
MRVL icon
716
Marvell Technology
MRVL
$174B
$53.6K ﹤0.01%
889
-977
-52% -$52.8K
HSIC icon
717
Henry Schein
HSIC
$9.74B
$53.4K ﹤0.01%
706
-854
-55% -$59.8K
BSM icon
718
Black Stone Minerals
BSM
$3.11B
$53.3K ﹤0.01%
3,337
-3,331
-50% -$57.3K
IFF icon
719
International Flavors & Fragrances
IFF
$19.4B
$53.1K ﹤0.01%
656
-620
-49% -$44.8K
RSPF icon
720
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$304M
$53.1K ﹤0.01%
906
-896
-50% -$47.6K
LEGN icon
721
Legend Biotech
LEGN
$4.3B
$53K ﹤0.01%
880
-810
-48% -$51.3K
OVV icon
722
Ovintiv
OVV
$17.5B
$52.7K ﹤0.01%
1,200
-1,100
-48% -$50.2K
IPG
723
DELISTED
Interpublic Group of Companies
IPG
$51.6K ﹤0.01%
1,581
-1,896
-55% -$57.1K
BFAM icon
724
Bright Horizons
BFAM
$3.99B
$51.5K ﹤0.01%
547
-433
-44% -$36.9K
TTE icon
725
TotalEnergies
TTE
$193B
$51.1K ﹤0.01%
758
-628
-45% -$41.9K

Similar funds

Clearstead Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Clearstead Advisors held 1,673 positions worth $1.88B, down 45% from $3.45B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Clearstead Advisors withdrew a net $1.8B in Q4 2023, closing 154 positions and reducing 1,274 holdings. Its most notable exit was iShares Morningstar Growth ETF, an estimated $36.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Clearstead Advisors opened a new position in State Street SPDR S&P Global Natural Resources ETF worth $502K.

  • Clearstead Advisors's largest Q4 2023 buy was State Street SPDR S&P Global Natural Resources ETF: 8,869 shares worth $502K.
  • Clearstead Advisors added most to Vanguard High Dividend Yield ETF in Q4 2023, an estimated $3.14M increase.
  • Clearstead Advisors's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $165M.
  • Clearstead Advisors fully exited iShares Morningstar Growth ETF in Q4 2023, selling an estimated $36.6M.
  • Clearstead Advisors's ten largest holdings make up 34% of its $1.88B portfolio in Q4 2023.
  • Clearstead Advisors opened 146 new positions and closed 154 in Q4 2023.
  • Clearstead Advisors's portfolio value fell 45% quarter-over-quarter to $1.88B.

Based on Clearstead Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.